We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M Turnover 69.61%
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
+10.58%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
–
AUM
$9.12M
AUM Growth
-$30.8M
Cap. Flow
-$30.4M
Cap. Flow %
-333.81%
Top 10 Hldgs %
37.71%
Holding
181
New
18
Increased
8
Reduced
44
Closed
108
Avg Time Held
1 year
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.1 years

Top Buys

Rank Stock Value
1
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$416K
2
CSGP icon
CoStar Group
CSGP
+$207K
3
DNOW icon
DNOW Inc
DNOW
+$192K
4
PLAB icon
Photronics
PLAB
+$131K
5
GYRE icon
Gyre Therapeutics
GYRE
+$92.2K

Top Sells

Rank Stock Value
1
CLCT
Collectors Universe
CLCT
+$605K
2
CTVA icon
Corteva
CTVA
+$581K
3
MTRN icon
Materion
MTRN
+$581K
4
NPTN
NEOPHOTONICS CORP
NPTN
+$556K
5
SPTN icon
SpartanNash
SPTN
+$543K

Sector Composition

Rank Sector Weight
1 Technology 36.92%
2 Healthcare 33.66%
3 Industrials 7.63%
4 Energy 5.22%
5 Consumer Staples 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KRSA
51
Korsana Biosciences, Inc. Common Stock
KRSA
$1.56B
$63K 0.69%
74
-76
-51% -$60.8K
2019 Q4
3 quarters
GRTS icon
52
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$57K 0.63%
+21,655
New +$80.4K
2020 Q3
0 quarters
ARAY icon
53
Accuray
ARAY
$19.8M
$54K 0.59%
22,354
-7,300
-25% -$17K
2015 Q4
19 quarters
ARC icon
54
DELISTED
ARC Document Solutions, Inc.
ARC
$54K 0.59%
60,143
-31,858
-35% -$33.7K
2015 Q4
19 quarters
SYBX icon
55
DELISTED
Synlogic
SYBX
$52K 0.57%
1,727
-1,013
-37% -$33.3K
2019 Q3
4 quarters
FLNT icon
56
Fluent
FLNT
$83.1M
$45K 0.49%
3,030
-1,467
-33% -$21.3K
2019 Q1
6 quarters
ATRS
57
DELISTED
Antares Pharma, Inc.
ATRS
$45K 0.49%
16,769
-28,800
-63% -$79.7K
2019 Q4
3 quarters
EMKR icon
58
DELISTED
Emcore Corp
EMKR
$44K 0.48%
1,339
-20
-1% -$661
2019 Q1
6 quarters
NAGE icon
59
Niagen Bioscience
NAGE
$203M
$43K 0.47%
+10,810
New +$52.1K
2020 Q3
0 quarters
CBIO icon
60
Crescent Biopharma
CBIO
$464M
$42K 0.46%
+138
New +$52.7K
2020 Q3
0 quarters
ETTX
61
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$42K 0.46%
+20,682
New +$59K
2020 Q3
0 quarters
COTY icon
62
Coty
COTY
$2.81B
$41K 0.45%
+15,200
New +$57.4K
2020 Q3
0 quarters
SVRA icon
63
Savara
SVRA
$976M
$40K 0.44%
+36,546
New +$62.5K
2020 Q3
0 quarters
LITS icon
64
Lite Strategy Inc
LITS
$36.5M
$39K 0.43%
+625
New +$37.7K
2020 Q3
0 quarters
RLH
65
DELISTED
Red Lions Hotel Corporation
RLH
$38K 0.42%
17,688
– –
2019 Q4
3 quarters
DRRX icon
66
DELISTED
DURECT Corp
DRRX
$36K 0.39%
2,088
+18
+0.9% +$361
2019 Q4
3 quarters
ALSK
67
DELISTED
Alaska Communications Systems
ALSK
$32K 0.35%
15,800
+1,000
+7% +$2.31K
2018 Q4
7 quarters
HOS icon
68
Hornbeck Offshore Services, Inc.
HOS
$2.2B
$31K 0.34%
+12,712
New +$46.4K
2020 Q3
0 quarters
YARW
69
Yarrow Bioscience
YARW
$162M
$25K 0.27%
+4
New +$23.3K
2020 Q3
0 quarters
SYNC
70
DELISTED
Synacor, Inc.
SYNC
$25K 0.27%
16,700
-3,700
-18% -$4.5K
2019 Q3
4 quarters
ABEO icon
71
Abeona Therapeutics
ABEO
$267M
$24K 0.26%
+924
New +$58.3K
2020 Q3
0 quarters
PVLA icon
72
Palvella Therapeutics
PVLA
$1.8B
$23K 0.25%
+136
New +$31K
2020 Q3
0 quarters
FET icon
73
Forum Energy Technologies
FET
$886M
$10K 0.11%
936
-735
-44% -$7.39K
2019 Q2
5 quarters
AA icon
74
Alcoa
AA
$10.6B
– –
-20,800
Closed -$234K –
ADSK icon
75
Autodesk
ADSK
$50.9B
– –
-1,079
Closed -$258K –
1 2
3
4 5

Similar funds

SC
Spindletop Capital Chappaqua, New York $8.71M AUM
KPC
Karst Peak Capital Hong Kong $8.61M AUM 270.01% 1-Year Est. Return
CIM
Castleton Investment Management Stamford, Connecticut $10M AUM 20.83% 1-Year Est. Return
BCIM
Burford Capital Investment Management Chicago, Illinois $6.17M AUM 38.81% 1-Year Est. Return
MVUM
Matrix VIII US Management Cambridge, Massachusetts $6.07M AUM 40.92% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return
FWCM
First Western Capital Management Los Angeles, California $4.71M AUM 11.17% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return

Alambic Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Alambic Investment Management held 181 positions worth $9.12M, down 77% from $39.9M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Alambic Investment Management withdrew a net $30.4M in Q3 2020, closing 108 positions and reducing 44 holdings. Its most notable exit was Collectors Universe, an estimated $605K position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alambic Investment Management opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock worth $81K.

  • Alambic Investment Management's largest Q3 2020 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 20,711 shares worth $81K.
  • Alambic Investment Management added most to Rimini Street in Q3 2020, an estimated $55.9K increase.
  • Alambic Investment Management's biggest Q3 2020 reduction was NEOPHOTONICS CORP, cutting an estimated $556K.
  • Alambic Investment Management fully exited Collectors Universe in Q3 2020, selling an estimated $605K.
  • Alambic Investment Management's ten largest holdings make up 38% of its $9.12M portfolio in Q3 2020.
  • Alambic Investment Management opened 18 new positions and closed 108 in Q3 2020.
  • Alambic Investment Management's portfolio value fell 77% quarter-over-quarter to $9.12M.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.